Pages that link to "Q38354341"
Jump to navigation
Jump to search
The following pages link to Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement (Q38354341):
Displaying 29 items.
- Leukemia associated antigens: their dual role as biomarkers and immunotherapeutic targets for acute myeloid leukemia (Q33491557) (← links)
- High expression of c-kit mRNA predicts unfavorable outcome in adult patients with t(8;21) acute myeloid leukemia (Q35361598) (← links)
- Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia (Q35548353) (← links)
- Comparative analysis of different approaches to measure treatment response in acute myeloid leukemia (Q36290737) (← links)
- Methods of minimal residual disease (MRD) detection in childhood haematological malignancies (Q36726108) (← links)
- Progress of minimal residual disease studies in childhood acute leukemia (Q36981845) (← links)
- Minimal residual disease quantitation in acute myeloid leukemia (Q37447344) (← links)
- Predictive factors of relapse and survival in childhood acute myeloid leukemia: role of minimal residual disease (Q37934964) (← links)
- Overview of therapy and strategies for optimizing outcomes in de novo pediatric acute myeloid leukemia (Q38196743) (← links)
- Quantitative monitoring of single nucleotide mutations by allele-specific quantitative PCR can be used for the assessment of minimal residual disease in patients with hematological malignancies throughout their clinical course (Q38340772) (← links)
- Clinical usefulness of the PAXgene™ bone marrow RNA system for stabilizing total RNA. (Q39009662) (← links)
- The quality of molecular response to chemotherapy is predictive for the outcome of AML1-ETO-positive AML and is independent of pretreatment risk factors (Q40231262) (← links)
- Prognostic value of real-time quantitative PCR (RQ-PCR) in AML with t(8;21). (Q40464781) (← links)
- Comments on the 2001 WHO proposal for the classification of haematopoietic neoplasms (Q40552437) (← links)
- BAALC expression: a suitable marker for prognostic risk stratification and detection of residual disease in cytogenetically normal acute myeloid leukemia (Q41885481) (← links)
- Long-term results in children with AML: NOPHO-AML Study Group--report of three consecutive trials (Q46817257) (← links)
- WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study (Q47594181) (← links)
- Methods of Detection of Measurable Residual Disease in AML. (Q47862030) (← links)
- Immunophenotypic differences between diagnosis and relapse in childhood AML: Implications for MRD monitoring. (Q52940970) (← links)
- Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia. (Q54203721) (← links)
- A >or=1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor acute myeloid leukemia and predicts subsequent morphologic relapse. (Q54545134) (← links)
- Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)]. (Q54631878) (← links)
- Development and evaluation of LAMP, CPA and IMSA methods for rapid detection of the fusion gene in acute myeloid leukemia (Q58733309) (← links)
- Monitoring of minimal residual disease in acute myeloid leukemia (Q79828937) (← links)
- Retrospective comparison of qualitative and quantitative reverse transcriptase polymerase chain reaction in diagnosing and monitoring the ALL1-AF4 fusion transcript in patients with acute lymphoblastic leukaemia (Q80468804) (← links)
- Prevalence and clinical implications of bone marrow involvement in pediatric anaplastic large cell lymphoma (Q80948275) (← links)
- [Acute leukemia in patients with Down syndrome] (Q81084073) (← links)
- Acute myeloid leukemias with recurrent genetic abnormalities: frequent assessment of minimal residual disease and treatment of molecular relapse with chemotherapy (Q81471211) (← links)
- Over-expression of BAALC and ERG is associated with poor outcome in acute myeloid leukemia (Q99205342) (← links)